Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Non-Current Assets (2018 - 2025)

Dna X (SONM) has disclosed Other Non-Current Assets for 8 consecutive years, with $725000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets fell 75.68% year-over-year to $725000.0, compared with a TTM value of $725000.0 through Sep 2025, down 75.68%, and an annual FY2024 reading of $948000.0, down 67.9% over the prior year.
  • Other Non-Current Assets was $725000.0 for Q3 2025 at Dna X, down from $780000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $5.1 million in Q2 2022 and bottomed at $431000.0 in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $2.7 million, with a median of $3.0 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets surged 1336.28% in 2021, then plummeted 88.46% in 2022.
  • Year by year, Other Non-Current Assets stood at $4.9 million in 2021, then increased by 4.87% to $5.1 million in 2022, then plummeted by 42.17% to $3.0 million in 2023, then tumbled by 67.9% to $948000.0 in 2024, then dropped by 23.52% to $725000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for SONM at $725000.0 in Q3 2025, $780000.0 in Q2 2025, and $821000.0 in Q1 2025.